OncLive® On Air
A podcast by OncLive® On Air
514 Episodes
-
S5 Ep43: Dietrich Details Data and Future Research With Immunotherapy in Stage III NSCLC
Published: 9/20/2021 -
S5 Ep42: Neel on Maximizing Research Strides in Oncology
Published: 9/16/2021 -
S5 Ep41: Loaiza-Bonilla Offers Guidance on Optimizing Treatment Selection in Pancreatic Cancer
Published: 9/13/2021 -
S5 Ep40: Lisberg Discusses the Promise of Datapotamab Deruxtecan in Lung Cancer
Published: 9/9/2021 -
S5 Ep39: McKay Filters Through Frontline Treatment Considerations in mRCC
Published: 9/6/2021 -
S5 Ep38: Sosa Talks Risk Factors, Rising Incidence, and Controversies in Thyroid Cancer
Published: 9/2/2021 -
S5 Ep37: Sekeres Previews Potential Combination Strategies in HR-MDS
Published: 8/30/2021 -
S5 Ep36: FDA Approval Insights: Nivolumab Plus Chemo for Frontline Gastric Cancer
Published: 8/26/2021 -
S5 Ep35: Krie and Yuan Talk Toxicity Management in Breast Cancer
Published: 8/23/2021 -
S5 Ep34: DFCI Faculty Relay Insight Into Confirmed Rebounds of Cancer Screenings After COVID-19
Published: 8/19/2021 -
S5 Ep33: Chachoua on Leveraging Screening Opportunities in Lung Cancer
Published: 8/16/2021 -
S5 Ep32: Making the Most of Molecular Testing in Breast Cancer
Published: 8/12/2021 -
S5 Ep31: FDA Approval Insights: Isatuximab Plus Carfilzomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Published: 8/9/2021 -
S5 Ep30: Research Reflections: Weber Relays Melanoma Updates From the 2021 ASCO Annual Meeting
Published: 8/5/2021 -
S5 Ep29: Rariy Reviews In-Home Infusion Initiative in Oncology
Published: 8/2/2021 -
S5 Ep28: Understanding Actionable Pathogenic Variants Among Caribbean Patients With Breast and Ovarian Cancers
Published: 7/29/2021 -
S5 Ep27: Analyzing the Advancing Applications for Next-Generation Sequencing in Lung Cancer
Published: 7/26/2021 -
S5 Ep26: FDA Approval Insights: Sacituzumab Govitecan in Urothelial Cancer
Published: 7/22/2021 -
S5 Ep25: Jabbour on Tailoring Treatment With TKIs in CML and Ph+ ALL
Published: 7/19/2021 -
S5 Ep24: Mayer on the Optimization of SERDs in ER+ Breast Cancer
Published: 7/15/2021
